Platelet concentrates for topical use: Bedside device and blood transfusion technology. Quality and versatility

Current Pharmaceutical Biotechnology

Volumn 13, Issue 7, 2012, Pages 1138-1144

  Borzini, Piero ^a   Balbo, Valeria ^a   Mazzucco, Laura ^a  

^a C Arrigo Children's Hospital   (Italy)

Author keywords

Platelet concentrates; Platelet rich plasma (PRP); Quality control; Quality management system; Standardization

Indexed keywords

THROMBOCYTE CONCENTRATE;

ABSOLUTE PLATELET CONTENT; ARTICLE; BEDSIDE DEVICE; BLOOD BANK; BLOOD TRANSFUSION; CENTRIFUGATION; HEALTH CARE COST; ITALY; MAXIMUM LEUKOCYTE CONTENT; MEDICAL DEVICE; PLATELET CONCENTRATION; POINT OF CARE TESTING; PRODUCT PARAMETERS; QUALITY CONTROL PROCEDURES; THROMBOCYTE VOLUME; TOTAL QUALITY MANAGEMENT; UNITED STATES;

EID: 84861147117     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112800624454     Document Type: Article

References (38)

1. Murphy, S. Platelets from pooled buffy coats: an update. Transfusion, 2005, 45(4), 634-639.
2. Price, T.H. Ed. Standards for blood banks and transfusion services. 2008, 25th ed. Bethesda, MD: American Association of Blood Banks (AABB).
3. Council of Europe. Guide to the Preparation, Use and Quality Assurance of Blood Components; 2009, 15th ed, Council of Europe Publishing.
4. Rosenthal, A.R.; Harbury, C.; Egbert, P.R.; Rubenstein, E. Use of a platelet-fibrinogen-thrombin mixture as a corneal adhesive: experiments with sutureless lamellar keratoplasty in the rabbit. Invest. Ophthalmol., 1975, 14(11), 872-875.
5. Fisher, H. A method for suture-free anastomosis of nerve transplantation is being reported, using facial nerve as example. Laryngol. Rhinol. Otol., 1979, 58(2), 154-156.
6. Knighton, D.R.; Ciresi, K.F.; Fiegel, V.D.; Austin, L.L.; Butler, E.L. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann. Surg., 1986, 204(3), 322-330.
7. Marx, R.E.; Carlson, E.R.; Eichstaedt, R.M.; Schimmele, S.R.; Strauss, J.E.; Georgeff, K.R. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral. Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 1998, 85(6), 638-646.
8. Dohan Ehrenfest, D.M.; Rasmusson, L.; Albrektsson, T. Classification of platelet concentrates: from pure platelet-rich plasma (PPRP) to leucocyte-and platelet-rich fibrin (L-PRF). Trends Biotechnol., 2009, 27(3), 158-167.
9. Dohan Ehrenfest, D.M.; Bielecki, T.; Mishra, A.; Borzini P.; Inchingolo, F.; Sammartino, G.; Rasmusson, L.; Everts, P.A.M. In search of a consensus terminology in the field of platelet concentrates for surgical use: Platelet-Rich Plasma (PRP), Platelet-Rich Fibrin (PRF), fibrin gel polymerization and leucocytes. Curr. Pharm. Biotechnol., 2011, 12. [Epub ahead of print].
10. Ministry of Health. Decreto 3 marzo 2005 Caratteristiche e modalità per la donazione del sangue e di emocomponenti. Gazzetta Ufficiale, 2005, 85, April 13th. Available from: http//:gazzetta.com.uni. gegi.anil/2005/85/3/html.
11. Borzini, P.; Mazzucco, L.; Giampaolo, A.; Hassan, H.J. Platelet gel - the Italian way: a call for procedure standardization and quality control. Transfus. Med., 2006, 16(4), 303-304.
12. Driver, V.R.; Hanft, J.; Fylling, C.P.; Beriou, J.M. Autologel Diabetic Foot Ulcer Study Group. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage, 2006, 52(6), 68-70, 72, 74 passim.
13. Martinengo, M.; Gallino, F.; Ardenghi, D.; Fornaro, N.; Calevo, M.G.; Tripodi, G. Productive plasmaplateletapheresis: a comparative study of the efficacy of two different separators. Blood Transfus., 2005, 3(4), 314-324. Available from: http://www.bloodtransfusion.it/articoli/ 000029/en/000092.pdf.
14. Weibrich, G.; Hansen, T.; Kleis W.; Buch, R.; Hitzler, W.E. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone, 2004, 34 (4), 665-671.
15. Everts, P.A.M.; Knape, J.T.A.; Weibrich, G.; Schönberger, J.P.A.M.; Hoffmann, J.; Overdevest, E.P.; Box, H.A.; van Zundert, A. Platelet-Rich Plasma and Platelet Gel: A Review. J. Extra Corpor. Technol., 2006, 38(2), 174-187.
16. Code of Federal Regulations. Title 42 CFR Part 493. Washington, DC. US Government Printing Office, 2004 (revised annually); Available from: http://wwwn.cdc.gov/clia/regs/subpartk.aspx#493. 1269.
17. Seidl, C.; O'Connell, M.; Delayney, F.; McMillan, Douglas, A.; Gorham, M.; van Krimpen, P.; Letowska, M.; Sobaga, L.; de Wit, J.; Seifried, E. on behalf of the Project's participants. European best practice in blood transfusion: improvement of quality-related processes in blood establishments. ISBT Science Series, 2007, 2(1), 143-149.
18. Guidelines for the Blood Transfusion Services in the UK. 2005, 7th Edition, TSO London. Available from: http://www.officialdocuments. gov.uk/ document/other/0117033715/0117033715.pdf.
19. Presidenza del Consiglio dei Ministri. "Aggiornamento del prezzo unitario di cessione del sangue e degli emocomponenti tra servizi sanitari pubblici", Repertorio Atti n. 1806 del 24 luglio, 2003 Available from: http://www.fidas.it/box_normativa/accordo_ aggiornamento_ tariffe.pdf.
20. Maryland Department of Health and Hygiene. Maryland Statewide Reduction of Blood Wastage Collaborative, Presentation 2009 September 22nd. Available from: http://dhmh.maryland.gov/mhqcc/ pdf/2009/oct09/ BWWG_09_22_09_Final.pdf.
21. Klein, A.A.; Nashef, S.A.; Sharples, L.; Bottrill, F.; Dyer, M.; Armstrong, J.; Vuylsteke, A. A randomized controlled trial of cell salvage in routine cardiac surgery. Anesth. Analg., 2008, 107(5), 1487-1495.
22. Centers for Medicare and Medicaid Services. CMS Proposes 2007 Outpatient Payment Rates http://www.aabb.org/Content/Programs_ and_Services/Billing_and_Reimbursement_Initiatives/07cmspropra te.htm.
23. Hsueh, J.C.; Ho, C.F.; Chang, S.H.; Pan, F.Z.; Chen, S.C.; Shi, M.D.; Chien, S.T. Blood surveillance and detection on platelet bacterial contamination associated with septic events. Transfus. Med., 2009, 19(6), 350-356.
24. Zimmermann, R.; Reske, S.; Metzler, P.; Schlegel, A.; Ringwald, J.; Eckstein, R. Preparation of highly concentrated and white cellpoor platelet-rich plasma by plateletpheresis. Vox Sang., 2008, 95(1), 20-25.
25. Appel, T.R.; Pötzsch, B.; Müller, J.; von Lindern, J.J.; Bergé, S.J.; Reich, R.H. Comparison of three different preparations of platelet concentrates for growth factor enrichment. Clin. Oral Implants. Res., 2002, 13(5), 522-528.
26. Weibrich, G.; Kleis, W.K.; Hitzler, W.E.; Hafner, G. Comparison of the platelet concentrate collection system with the plasma-richin-growth-factors kit to produce platelet-rich plasma: a technical report. Int. J. Oral Maxillofac. Implants, 2005, 20(1), 118-123.
27. Everts, P.A. M; Hoffmann, J.; Weibrich, G.; Mahoney, C.B.; Schönberger, J.P.; van Zundert, A.; Knape, J.T. Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation. Transfus. Med., 2006, 16(5), 363-368.
28. Leitner, G.C.; Gruber, R.; Neumüller, J.; Wagner, A.; Kloimstein, P.; Höcker, P.; Körmöczi, G.F.; Buchta, C. Platelet content and growth factor release in platelet-rich plasma: a comparison of four different systems. Vox Sang., 2006, 91(2), 135-139.
29. Mazzucco, L.; Balbo, V.; Cattana, E.; Guaschino, R.; Borzini, P. Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang., 2009, 97(2), 110-118.
30. Klein, H.G. How safe is blood, really? Biologicals, 2010, 38(1), 100-104.
31. Trimble, S.R.; Parker, C.S.; Grant, A.M.; Soucie, J.M.; Reyes, N. Assessing emerging infectious threats to blood safety for the blood disorders community. Am. J. Prev. Med., 2010, 38(4S), S468-474.
32. Mohan, K.V.; Rao, S.S.; Atreya, C.D. Evaluation of antimicrobial peptides as novel bactericidal agents for room temperature-stored platelets. Transfusion, 2010, 50(1), 166-173.
33. Osselaer, J.C.; Doyen, C.; Defoin, L.; Debry, C.; Goffaux, M.; Messe, N.; Van Hooydonk, M.; Bosly, A.; Lin, J.S.; Lin, L.; Corash, L. Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use. Transfusion, 2009, 49(7),1412-1422.
34. Picardi, A,; Lanti, A.; Cudillo, L.; Cerretti, R.; Dentamaro, T.; De Angelis, G.; Ferraro, A.; Di Veroli, A.; Adorno, G.; Arcese, W. Platelet gel for treatment of mucocutaneous lesions related to graftversus-host disease after allogeneic hematopoietic stem cell transplant. Transfusion, 2010, 50 (2), 501-506.
35. Chen, T.M.; Tsai, J.C.; Burnouf, T. A novel technique combining platelet gel, skin graft, and fibrin glue for healing recalcitrant lower extremity ulcers. Dermatol. Surg., 2010, 36(4), 453-460.
36. Smrke, D.; Gubina, B.; Domanovic, D.; Rozman, P. Allogeneic platelet gel with autologous cancellous bone graft for the treatment of a large bone defect. Eur. Surg. Res., 2007, 39(3), 170-174.
37. Perseghin, P.; Sciorelli, G.; Belotti, D.; Speranza, T.; Pogliani, E.M.; Ferro, O.; Gianoli, M.; Porta, F; Paolini, G. Frozen-andthawed allogeneic platelet gels for treating postoperative chronic wounds. Transfusion, 2005, 45(9), 1544-1546.
38. Greppi, N.; Mazzucco, L.; Galetti, G.; Bona, F.; Petrillo, E.; Smacchia, C.; Raspollini, E.; Cossovich, P.; Caprioli, R.; Borzini, P.; Rebulla, P.; Marconi, M. Treatment of recalcitrant ulcers with allogeneic platelet gel from pooled platelets in aged hypomobile patients. Biologicals, 2011, 39(2), 73-80.